Test Price
2,800 AED✅ Home Collection Available
FGFR1 Gene Osteoglophonic Dysplasia Genetic Test in Dubai, UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited (Cert: INT/EGQ/2509DA/3139) and DHA-licensed facility (License 1143).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (available daily from 8 AM to 11 PM across all seven emirates).
- Clinical Guidance: Telephonic post-test genetic counseling by DHA-certified genetic counselors.
- Insurance Support: Direct billing verification via WhatsApp: +971 54 548 8731.
Test Overview & Methodology
This test sequences the entire coding region of the FGFR1 gene to detect pathogenic variants causing osteoglophonic dysplasia, a rare craniofacial and skeletal disorder. Early molecular diagnosis enables precise clinical management and genetic counseling for affected families across the UAE.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | NGS with LC-MS/MS validation | Automated Sanger sequencing |
| Coverage | Full gene + flanking intronic regions | Exon-by-exon, may miss deep intronic variants |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
| UAE Regulatory Compliance | DHA regulated, Federal Decree-Law No. 45 of 2021 (PDPL), Federal Law No. 2 of 2019 | Basic accreditation |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize that FGFR1 mutation interpretation requires integration with clinical and radiological findings. A negative NGS result does not exclude the diagnosis; a positive result necessitates multidisciplinary evaluation. Family history remains the cornerstone of accurate counseling.”
— Lina Osama Zaki Quteineh, DHA: 9294403
Medication Advisory
Do not discontinue any prescribed medication without consulting your treating physician. Routine drugs do not affect genetic testing, but abrupt changes may harm your health.
Exclusion Criteria & Emergency Red Flags
- Acute febrile illness or systemic infection at time of collection – reschedule after recovery.
- Known allergy to phlebotomy materials (latex, antiseptic) – inform the phlebotomist in advance.
- If you experience severe dizziness, fainting, or uncontrolled bleeding after sample collection, seek immediate ER care.
- Test not intended for prenatal diagnosis; consult a genetic counselor for invasive prenatal options.
Patient FAQ & Clinical Guidance
1. How accurate is the FGFR1 NGS test for osteoglophonic dysplasia?
The test achieves 99.9% diagnostic sensitivity for known pathogenic FGFR1 variants when performed on high-quality DNA from blood or FTA card samples. Our NGS platform reads the entire FGFR1 gene with >100x depth, then every suspicious variant is confirmed by LC-MS/MS, eliminating false positives. This exceeds international standards and aligns with DHA guidelines for genetic diagnostics.
2. What is the expected turnaround time for results?
Results are available within 3 to 4 weeks from sample receipt at our DHA-licensed laboratory. NGS technology combined with clinical review ensures a comprehensive final report detailing pathogenic mutations and medical interpretation.
3. Is home collection available for a child suspected of osteoglophonic dysplasia?
Yes, our pediatric-trained phlebotomists provide hospital-grade home collection across all seven emirates, using butterfly needles for minimal discomfort in children. A parent or legal guardian must be present and provide written consent. Samples are transported in temperature-controlled coolers directly to our Dubai laboratory. We also offer genetic counseling before and after the test via tele-health.
UAE Regulatory & Data Privacy Adherence
UAE Regulatory Compliance
This test is performed in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree-Law No. 4 of 2016 on Medical Liability. Patient data is encrypted and stored on ISO 27001-certified servers located in the UAE.
DHA Facility License: 1143 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Support: +971 54 548 8731
Clinical & Logistical Metadata
| Test Name | FGFR1 Gene Osteoglophonic Dysplasia Genetic Test |
| Price (AED) | 2800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card (Peripheral Blood) |
| Methodology Used | Next-Generation Sequencing (NGS) with LC-MS/MS Validation |
| ICD-10-CM Code | Q78.8 |
| LOINC Code | 92681-3 |
| DHA Facility License & Laboratory Address | DHA License 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians